Clinical trial
Flt3L in Treating Patients With Metastatic Colorectal Cancer
NCT00003431 · Duke University, Other · Completed
Key facts
| NCT number | NCT00003431 |
|---|---|
| Title | Flt3L in Treating Patients With Metastatic Colorectal Cancer |
| Official title | Pilot Study of FLT3 Ligand Prior to Resection of Hepatic Metastases of Colorectal Cancer |
| Lead sponsor | Duke University, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Colorectal Cancer, Metastatic Cancer |
| Intervention type | Biological |
| Interventions | recombinant flt3 ligand |
| Start date | Jun 1, 1998 |
| Completion | May 1, 2001 |
| First posted | Aug 4, 2004 |
| Last update posted | Mar 5, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: